dc.contributor.author | Pérez Lanzón M. | |
dc.contributor.author | Maiuri, M. C. | |
dc.contributor.author | López Otín, Carlos | |
dc.contributor.author | Kroemer, G. | |
dc.date.accessioned | 2023-11-07T09:59:33Z | |
dc.date.available | 2023-11-07T09:59:33Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | OncoImmunology, 12(1), (2023); doi:10.1080/2162402X.2023.2240613 | |
dc.identifier.issn | 2162-4011 | |
dc.identifier.uri | https://hdl.handle.net/10651/70257 | |
dc.description.sponsorship | European Joint Programme on Rare Diseases (EJPRD); European Research Council Advanced Investigator Award (ERC-2021-ADG, ICD-Cancer, Grant No. 101052444), European Union Horizon 2020 Projects Oncobiome, Prevalung (grant No. 101095604) and Crimson; Fondation Carrefour; Institut National du Cancer (INCa); Institut Universitaire de France; LabEx Immuno-Oncology (ANR-18-IDEX-0001); a Cancer Research ASPIRE Award from the Mark Foundation; the RHU Immunolife; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and SIRIC Cancer Research and Personalized Medicine (CARPEM). This study contributes to the IdEx Université de Paris ANR-18-IDEX-0001. | |
dc.language.iso | eng | |
dc.relation.ispartof | OncoImmunology | |
dc.rights | © 2023 The Author(s). | |
dc.rights | CC Reconocimiento 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.source | Scopus | |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85166762710&doi=10.1080%2f2162402X.2023.2240613&partnerID=40&md5=88c39153c62c4a2441372a256a476d61 | |
dc.title | Mammary carcinoma: toward a realistic mouse model of incurable cancers | |
dc.type | journal article | |
dc.identifier.doi | 10.1080/2162402X.2023.2240613 | |
dc.relation.projectID | ERC-2021-ADG, ICD-Cancer, Grant No. 101052444 | |
dc.relation.projectID | grant No. 101095604 | |
dc.relation.publisherversion | http://dx.doi.org/10.1080/2162402X.2023.2240613 | |
dc.rights.accessRights | open access | |